Myeloperoxidase: A versatile mediator of endothelial dysfunction and therapeutic target during cardiovascular disease
Accessed 10 December 2021 Parisy V, Poinssot B, Owsianowski L, Buchala A, Glazebrook J, Mauch F (2007) Identification of PAD2 as a gamma-glutamylcysteine synthetase highlights the importance of glutathione in disease resistance of Arabidopsis
Clinical trials of GLP-1RAs have primarily focused on patients with obesity or overweight, yet the effectiveness in the cardiovascular protection appears independent of baseline BMI range (265)
The peer-reviewed evidence on glutathione and skin lightening documents the tyrosinase-inhibiting mechanism and the cumulative dose-response relationship behind regular administration for brightening goals
Interactions with other medications are a primary concern, and all of these can require close medical monitoring
The cure is usually rest, barrier repair, and a more careful reintroduction at a lower frequency